Syntr Health Technologies develops and tests a processing device for the micro fragmentation of adipose tissue for body contouring.
Syntr Health Technologies's investors include Propel(X), MassChallenge, Sunstone Management, Titan Angels.
Syntr Health Technologies is headquartered in Irvine, United States.
Syntr Health Technologies develops and tests a processing device for the micro fragmentation of adipose tissue for body contouring.
Syntr Health Technologies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Syntr Health Technologies — Funding & Investors." VCBacked, August 1, 2022, https://www.vcbacked.co/company/syntr-health-technologies. Accessed August 14, 2026.
VCBacked. (2022). Syntr Health Technologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/syntr-health-technologies
{{cite web |title=Syntr Health Technologies — Funding & Investors |url=https://www.vcbacked.co/company/syntr-health-technologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated